Department of Pediatrics

Education

• BA, Tufts University, 2002
• MD, New York University School of Medicine, 2007

Training

• Resident, Pediatrics, Children's Hospital of Philadelphia, 2007 - 2010
• Fellow, Pediatric Infectious Diseases/Pediatric Hematology-Oncology, Children's Hospital of Philadelphia, 2010 - 2014
• Post-doctoral fellow, lab of Dr. Matthew Weitzman, Children's Hospital of Philadelphia, 2014 - 2015

Licensure and Board Certification

• 2007General Pediatrics, American Board of Pediatrics
• 2009 - 2021PA, Medical License
• 2015Hematology-Oncology, American Board of Pediatrics
• 2015Infectious Diseases, American Board of Pediatrics
• 2019 - PresMO, Medical Physician and Surgeon

Honors and Awards

• Eagles Fly for Leukemia Scholar, 2012 - 2014
• Selected to attend the 22nd Annual AACR Workshop: Molecular Biology in Clinical Oncology, 2013
• Canuso Foundation Innovation Award, 2014
• Alex's Lemonade Stand Foundation Young Investigator Award, 2014 - 2016
• Translational Research Scholar in Hematologic Malignancies, CHOP Center for Childhood Cancer Research, 2018
• Cancer Research Foundation Young Investigator Award, 2021
• Virtual Cancer Center Scholar, 2021

Recent Publications view all (13)

1. Otto WR, Green A. Antiviral Therapeutics in Pediatric Transplant Recipients. Infect Dis Clin North Am. 2022;36(1):125-146. PMCID:PMC8900721  PMID:35168706 
2. Berrios KN, Evitt NH, DeWeerd RA, Ren D, Luo M, Barka A, Wang T, Bartman CR, Lan Y, Green AM, Shi J, and Kohli RM . Controllable genome editing with split-engineered base editors Nat Chem Bio. 2021. 
3. DeWeerd RA and Green AM. Qualitative and quantitative analysis of DNA-cytidine deaminase activity Methods Mol Biol. 2021. 
4. Green AM, DeWeerd RA, O'Leary DR, Hansen AR, Hayer KE, Kulej K, Dineen AS, Szeto JH, Garcia BA, Weitzman MD.. Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity EMBO Rep. 2021;e52145. doi:10.15252/embr.202052145  PMID:34347354 
5. Otto WR, Green AM. Fungal infections in children with haematologic malignancies and stem cell transplant recipients Br J Haematol. 2020;189(4):607-624. doi:10.1111/bjh.16452  PMID:32159231  
6. Green AM, Weitzman MD. The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities DNA Repair. 2019;83:102700. doi:10.1016/j.dnarep.2019.102700  PMID:31563041  
7. Kitt E, Hayes M, Cardenas AM, and Green AM. Interpretation and management of positive anti-hepatitis B core antibody tests in immunocompromised pediatric patients. Transpl Infect Dis. 2019;21(3):e13074. doi:10.1111/tid.13074  PMID:30868720 
8. Chang YC, Graf E, Green AM. Invasive Curvularia Infection in Pediatric Patients With Hematologic Malignancy Identified by Fungal Sequencing. J Pediatric Infect Dis Soc. 2018. PMID:30265347 
9. Green AM, Budagyan K, Hayer KE, Reed MA, Savani MR, Wertheim GB, Weitzman MD. Cytosine Deaminase APOBEC3A sensitizes leukemia cells to inhibition of the DNA replication checkpoint. Cancer Res. 2017;77(17):4579-4588. PMCID:5581702   PMID:28655787 
10. Green AM, Landry S, Budagyan K, Avgousti DC, Shalhout S, Bhagwat AS, and Weitzman MD. APOBEC3A damages the cellular genome during DNA replication. Cell Cycle. 2016;15(7):998-1008. PMCID:26918916  PMID:26918916  
11. Delgado J, Bedoya MA, Green AM, Jaramillo D, Ho-Fung V. Utility of unenhanced fat-suppressed T1-weighted MRI in children with sickle cell disease -- can it differentiate bone infarcts from acute osteomyelitis? Pediatr Radiol. 2015;45(13):1981-7. PMID:26209118 
12. De Blank P, Cole K, Kersun L, Green A, Wilkes JJ, Belasco J, Bagatell R, Bailey LC, Fisher MJ. fdg-pet in two cases of neurofibromatosis type 1 and atypical malignancies. Curr Oncol. 2014;21(2):e345-8. PMCID:PMC3997466  PMID:24764718 
13. Green A. An Adolescent With Hepatitis. J Ped Infect Dis. 2012;1(1):81-83. PMID:26618696